Review Explores Racial Disparities in Aortic Stenosis Diagnosis and Treatment
JANUARY 24, 2020
Kevin Thomas, MD
Results of the review, which included more than a dozen studies published between 2001 and 2019, revealed discrepancies in the diagnosis, treatment, and outcomes for patients with severe aortic stenosis based on a patient’s race or ethnic group.
To explore the ever-growing base of aortic stenosis data, investigators—led by Kevin Thomas, MD, associate professor of medicine at Duke University—conducted a review of the PubMed, Scopus, and Web of Science databases. Search terms used in the review were: “aortic valve stenosis or aortic stenosis,” “minority,” “ethnic groups,” “African Americans,” “blacks,” “Hispanics,” “Latinos,” “Mexican American,” “Asian,” “Pacific Islander,” “Asian American,” “Native American,” “Indian,” “Caucasian,” “European American,” “disparity,” and “bias.”
A total of 31 published articles and abstracts focusing on diverse racial populations with severe aortic stenosis were identified and 15 were included in the review. Using data from these studies, authors go on to break down differences in prevalence, surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR), and outcomes in separate sections.
The team highlighted multiple studies that described the difference in prevalence among racial and ethnic groups. Including a 2016 study that assessed the prevalence and found black (0.68, 95% CI: 0.66-0.71), Hispanic (0.79, 0.76-0.84), and Asian (0.68, 0.64-0.74) patients all had a lower risk of diagnosis than white patients. A 2014 study that used echocardiographic data from 272,429 patients found severe aortic stenosis in 0.29% of black patients and 0.91% of white patients.
A number of significant differences were noted when assessing racial differences in the management of severe aortic stenosis—notably, 4 studies that found underrepresented ethnic groups were less likely to undergo SAVR compared with white patients. Thomas and colleagues also outlined 2 other studies, a 2013 study that found black patients underwent SAVR less often than white patients (39% vs. 53%; P = .02) and a 2018 study examining the same issue in 96,278 patients that also found black patients were less likely to undergo SAVR than white patients (6.7% vs. 11.3%; P < .001).
The disparities became even more pronounced when examining TAVR. An analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry from 2012 to 2014 indicated black patients underwent TAVR at a fraction of the rate white patients did (3.8% vs. 93.8%). An additional study from 2017 found black patients were less likely to undergo TAVR—this study also found odds of undergoing TAVR increased 10% with every $10,000 increase in income.
Multiple differences were observed when assessing disparities in outcomes by ethnicity and race. A 2018 study examining patients 60 and older found that, compared to white patients, black patients had a higher crude mortality rate following AVR (6.4% vs. 4.7%; P <.001), longer hospitalizations(12±12 days vs. 10±9 days; P < .001), increased cost of hospitalization ($55,631±$37,773 vs. $52,521±$38,040; P < .001), and higher rates of discharge to skilled nursing facilities or nursing homes(32.1% vs. 27.2%; P=.004).
A 2013 study examining 3-year survival rates after AVR found black and white patients had similar results (49% [95% CI: 38% - 60%] vs. 50% [95% CI: 45% - 54%]; P = .31). A 2016 study indicated Asians who underwent TAVR had a procedural success rate of 97.5% and 30-day and 1-year mortality rates were 2.5% (P = .12) and 10.8% (P = .40).
Based on the results of their analysis, the team of authors suggests a greater commitment to researching these disparities will only help to aid in decreasing the gap between racial and ethnic groups.
This review, titled “Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic Stenosis,” was published online in JACC.
MDNN: CVS Health Buys Aetna, D-cycloserine for Tuberculosis, Unsafe Abortions, and Childhood Obesity